About
Policy Positions
News
Glossary
Privacy Policy
Join
Contact

Home / Policy Positions / The Gray Sheet Interview with Brad Thompson

Comments OffDecember 21, 2012by adminin

Policy Positions

The Gray Sheet Interview with Brad Thompson

http://www.ebglaw.com/files/47709_Thompson-Gray-Sheet-Interview-11-22-2011-Epstein.pdf

FDA’s Approach to Clinical Decision Support Software: A Brief Summary →← FDA checking high-risk medical apps for safety

Like this post?

0

Tweet

More sharing options

About the author

admin

More posts

Popular
Latest

No Popular Posts Found

CDS Coalition Files Citizens Petition at FDA Objecting to the Agency’s 2022 Final Guidance on Clinical Decision Support Software

CDS Coalition Provides Comments on FDA’s Reproposed “Clinical Decision Support Software: Draft Guidance for Industry and FDA Staff”

Startup Roadshow Encore Webinar: AI in Healthcare

Startup Roadshow: FDA Regulation of Artificial Intelligence Used in Healthcare

Recent Posts

CDS Coalition Files Citizens Petition at FDA Objecting to the Agency’s 2022 Final Guidance on Clinical Decision Support Software
CDS Coalition Provides Comments on FDA’s Reproposed “Clinical Decision Support Software: Draft Guidance for Industry and FDA Staff”
Startup Roadshow Encore Webinar: AI in Healthcare
Startup Roadshow: FDA Regulation of Artificial Intelligence Used in Healthcare
CDS Coalition Provides Feedback on Version 0.2 of FDA’s Software Precertification Program Working Model

CDS Coalition website is published for informational purposes only; it contains no legal or medical advice whatsoever.